Get startedLog in
    Picture of Percheron Therapeutics logo

    PER — Percheron Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Percheron Therapeutics Seeks Trading Halt Pending In Relation To Initial Top Line Data For Company's Phase IIB Clinical Trial

    Picture of Percheron Therapeutics logoPercheron Therapeutics
    16/12/2024 01:08
    Dec 16 (Reuters) - Percheron Therapeutics Ltd  PER.AX :
    * TRADING HALT PENDING IN RELATION TO INITIAL TOP LINE DATA
FOR
COMPANY'S PHASE IIB CLINICAL TRIAL


Further company coverage:  PER.AX 

 ((Reuters.Briefs@thomsonreuters.com))

    Recent news on Percheron Therapeutics

    See all news